{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:22:21Z","timestamp":1790738541434,"version":"4.1.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Postpartum hemorrhage (PPH) affects up to 44% of women with von Willebrand disease (VWD) despite von Willebrand factor (VWF) replacement. Because tranexamic acid (TXA) reduced PPH-related deaths in the WOMAN trial, we assessed whether TXA combined with rVWF vs rVWF alone prevents PPH in VWD. VWD-Woman, a phase 3, open-label, randomized pilot trial, enrolled pregnant women with VWD, aged \u226518 years (von Willebrand Factor Ristocetin Cofactor activity [VWF:RCo] of &amp;lt;0.50 IU\/mL, bleeding history). Participants received IV rVWF 80 IU\/kg at delivery and postpartum days 1 and 2, with or without TXA (1 g within 3 hours of delivery). The primary outcome was quantitative blood loss (QBL) at delivery. Secondary outcomes included 21-day pictorial blood assessment chart (PBAC) scores, hemoglobin changes, transfusions, hysterectomy, and safety. Of 103 screened, 40 were eligible, and 20 enrolled (10 per group), 100% were iron-deficient. Mean QBL was similar (TXA + rVWF: 727.0 mL; 95% CI, 434.5-1019.5] vs rVWF: 539.7 mL [95% CI, 132.8-946.6]; P = 0.41), as were rates of PPH (30% in both groups). No differences were observed in hemoglobin change (\u22121.90 g\/dL vs \u22121.42 g\/dL, P = 0.49) or 21-day PBAC score (467.1 vs 344.8, P = 0.32). Stratified analyses showed no differences by age, body mass index, VWF activity, or delivery type. No serious adverse events or thrombosis occurred. TXA plus rVWF is feasible and safe in type 1 VWD, but in this small pilot study, was not associated with a reduction in PPH compared with rVWF alone. Iron deficiency is prevalent. Further studies are needed to improve PPH prevention in VWD. This trial was registered at www.ClinicalTrials.gov as #NCT04344860.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017046","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:01:03Z","timestamp":1756926063000},"page":"6031-6039","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Impact of tranexamic acid on postpartum hemorrhage in type 1 von Willebrand disease treated with recombinant VWF"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2776-8987","authenticated-orcid":false,"given":"Nicoletta C.","family":"Machin","sequence":"first","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Brooks","sequence":"additional","affiliation":[{"name":"3Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Vehec","sequence":"additional","affiliation":[{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ivanco","sequence":"additional","affiliation":[{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lawryk","sequence":"additional","affiliation":[{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Seaman","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Xavier","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3535-2113","authenticated-orcid":false,"given":"Sruti","family":"Shiva","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"4Department of Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Verdoni","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"5Vitalant Coagulation Laboratory, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7830-5379","authenticated-orcid":false,"given":"Margaret V.","family":"Ragni","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Division of Classical Hematology, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"2Hemophilia Center of Western PA, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"2025120910512927000_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2025120910512927000_bib2","doi-asserted-by":"crossref","first-page":"12.e1","DOI":"10.1016\/j.ajog.2009.04.024","article-title":"von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel","volume":"201","author":"James","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2025120910512927000_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2010.02.036","article-title":"von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment","volume":"203","author":"Pacheco","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"19","key":"2025120910512927000_bib4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","volume":"136","author":"Leebeek","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2025120910512927000_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/ejh.13562","article-title":"Assessment of von Willebrand disease and pregnancy outcomes at regional Australian hospitals","volume":"106","author":"Wilson","year":"2021","journal-title":"Eur J Haematol"},{"issue":"4","key":"2025120910512927000_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey","volume":"21","author":"Stoof","year":"2015","journal-title":"Haemophilia"},{"issue":"10","key":"2025120910512927000_bib7","doi-asserted-by":"crossref","first-page":"e0164683","DOI":"10.1371\/journal.pone.0164683","article-title":"Postpartum hemorrhage in women with von Willebrand disease - a retrospective observational study","volume":"11","author":"Govorov","year":"2016","journal-title":"PloS one"},{"issue":"6","key":"2025120910512927000_bib8","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2025120910512927000_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12884-023-05702-6","article-title":"Exploring trends of severe postpartum haemorrhage: a hospital-based study","volume":"23","author":"Pettersen","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"2025120910512927000_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31826d60c5","article-title":"Severe maternal morbidity among delivery and postpartum hospitalizations in the United States","volume":"120","author":"Callaghan","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2025120910512927000_bib11","author":"WHO","year":"2023"},{"issue":"4","key":"2025120910512927000_bib12","first-page":"e168-e186","article-title":"Practice Bulletin No. 183: postpartum hemorrhage","volume":"130","author":"Committee on Practice Bulletins-Obstetrics","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025120910512927000_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/bloodadvances.2021005589","article-title":"Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature","volume":"6","author":"Brignardello-Petersen","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"2025120910512927000_bib14","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/jog.14834","article-title":"Prenatal anemia and postpartum hemorrhage risk: a systematic review and meta-analysis","volume":"47","author":"Omotayo","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"issue":"7","key":"2025120910512927000_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1701-2163(16)30551-5","article-title":"Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"27","author":"Demers","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"2025120910512927000_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"1","key":"2025120910512927000_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"2025120910512927000_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"5-6","key":"2025120910512927000_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"issue":"2","key":"2025120910512927000_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2025120910512927000_bib21","doi-asserted-by":"crossref","first-page":"e2013052","DOI":"10.4084\/mjhid.2013.052","article-title":"Changes of von Willebrand factor during pregnancy in women with and without von Willebrand disease","volume":"5","author":"Castaman","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"2025120910512927000_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000496820","article-title":"The course of von Willebrand factor and factor VIII activity in patients with von Willebrand disease during pregnancy","volume":"142","author":"Delbr\u00fcck","year":"2019","journal-title":"Acta Haematol"},{"issue":"1","key":"2025120910512927000_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jth.15561","article-title":"Examining international practices in the management of pregnant women with von Willebrand disease","volume":"20","author":"Lavin","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025120910512927000_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/hae.14953","article-title":"Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: outcomes at a single-institution cohort study","volume":"30","author":"Lim","year":"2024","journal-title":"Haemophilia"},{"issue":"3","key":"2025120910512927000_bib25","doi-asserted-by":"crossref","first-page":"e18792","DOI":"10.1097\/MD.0000000000018792","article-title":"Tranexamic acid for postpartum hemorrhage prevention in vaginal delivery: a meta-analysis","volume":"99","author":"Xia","year":"2020","journal-title":"Medicine"},{"issue":"4","key":"2025120910512927000_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ajog.2021.09.025","article-title":"Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis","volume":"226","author":"Bellos","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025120910512927000_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-4165(81)90312-3","article-title":"Studies on the mechanism of the antifibrinolytic action of tranexamic acid","volume":"673","author":"Hoylaerts","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"2025120910512927000_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur","year":"2010","journal-title":"Trials"},{"issue":"8","key":"2025120910512927000_bib29","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1016\/S2352-3026(23)00119-9","article-title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","volume":"10","author":"Ragni","year":"2023","journal-title":"Lancet Haematol"},{"issue":"4","key":"2025120910512927000_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/AOG.0b013e3181f20177","article-title":"Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial","volume":"116","author":"Lukes","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025120910512927000_bib31","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000003564","article-title":"Quantitative blood loss in obstetric hemorrhage: ACOG COMMITTEE OPINION, Number 794","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"8","key":"2025120910512927000_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"2025120910512927000_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12884-015-0653-6","article-title":"Is accurate and reliable blood loss estimation the \u2018crucial step\u2019 in early detection of postpartum haemorrhage: an integrative review of the literature","volume":"15","author":"Hancock","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"2025120910512927000_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/ejh.13870","article-title":"The incidence, complications, and treatment of iron deficiency in pregnancy","volume":"109","author":"Benson","year":"2022","journal-title":"Eur J Haematol"},{"issue":"11","key":"2025120910512927000_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.2024.13546","article-title":"Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"332","author":"Cantor","year":"2024","journal-title":"JAMA"},{"issue":"suppl 2","key":"2025120910512927000_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ijgo.14951","article-title":"The importance of iron deficiency in pregnancy on fetal, neonatal, and infant neurodevelopmental outcomes","volume":"162","author":"Georgieff","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2025120910512927000_bib37","doi-asserted-by":"crossref","first-page":"e70061","DOI":"10.1002\/hem3.70061","article-title":"Replacement therapy in pregnant women with von Willebrand disease during delivery: factor levels and pharmacokinetics","volume":"9","author":"Al Arashi","year":"2025","journal-title":"HemaSphere"},{"issue":"suppl 1","key":"2025120910512927000_bib38","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2024-193986","article-title":"Postpartum hemorrhage in women with von Willebrand disease after enhanced prophylactic clotting factor suppletion: the Pregnancy and Inherited Bleeding Disorders Study (PRIDES)","volume":"144","author":"De Vaan","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2025120910512927000_bib39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jtha.2023.11.009","article-title":"Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis","volume":"22","author":"Raska","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2025120910512927000_bib40","doi-asserted-by":"crossref","first-page":"102727","DOI":"10.1016\/j.bcmd.2023.102727","article-title":"Impact of maternal iron deficiency anemia on fetal iron status and placental iron transporters in human pregnancy","volume":"99","author":"Santhakumar","year":"2023","journal-title":"Blood Cells Mol Dis"},{"issue":"suppl 4","key":"2025120910512927000_bib41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/anae.15405","article-title":"The effect of iron deficiency and anaemia on women\u2019s health","volume":"76","author":"Benson","year":"2021","journal-title":"Anaesthesia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6031\/2423726\/blooda_adv-2025-017046-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/23\/6031\/2423726\/blooda_adv-2025-017046-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:51:40Z","timestamp":1765295500000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/23\/6031\/547097\/Impact-of-tranexamic-acid-on-postpartum-hemorrhage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":41,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017046","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,9]]},"published":{"date-parts":[[2025,11,26]]}}}